Donald Trump’s upset presidential win had pharmaceutical stocks reversing course upward on Wednesday.
Some of the sector’s woes had been due to concerns that a Hillary Clinton presidency would challenge the industry and its business practices. With Trump as president-elect, the Biotechnology Index shot up by more than 8.8% on Wednesday.
To be sure, these kinds of one-day gains aren’t likely to be sustainable. The market will soon correct itself.
